FDA Investigator Yvesna C Blaise

Yvesna C Blaise has conducted inspections on 65 sites in 7 countries as of 22 Jun 2021. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
65
Last Inspection Date:
22 Jun 2021
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Malta, Mexico, Israel, Portugal, Italy
FDA Investigators that have inspected at least one site in common with Yvesna C Blaise:
Addam S Reynolds, Adetutu M Gidado, Aditi S Thakur, Alan M Barker, Alberto A Viciedo, Alice S Tsao, Allen Lou, Amatul H Marium, Amit Kokate, Amy L Singer, Amy M Codella, Amy M Cramer, Anastasia I Offordile, Angela E Glenn, Anissa M Vargas, Anita R Michael, Ankur C Patel, Annemarie Bodnar, Annet R Rajan, Anthony J Donato, Anthony M Criscuolo, Jr, Atul J Agrawal, Azeezat M Lawal, Barbara J Maulfair, Barbara Jwilimczyk Macri, Bijoy Panicker, Bruce G Cooper, Byungja E Marciante, Carl A Perez, Cary Greene, Caryn M Mcnab, CDR Rochelle B Young, RPh, MSA, Charles J Chacko, Charles M Edwards, Charles R Cote, RIC, Charles Yuanchia Kuo, PhD, Cheryl A Grandinetti, Christian F Gomez Lugo, Christina K Theodorou, Christina N Maurino, Christine M Cerenzio, Concepcion Cruz, Jr, Cynthia A Palmer, Cynthia J Lee, MS, Daniel J Grabicki, Daniel L Aisen, Daniel L Zheng, David A Oluwo, David H Smith, David M Mcnew, Dawn L Wydner, Deborah A Greco, Deborah B Nixon, Deborah M Trout, Denise M Digiulio, Denise M Visco, Investigator, Derek S Smith, PhD, Devon Jenkins, Deyaa Shaheen, Dorothy J Denes, Douglas C Kovacs, Douglas G Ng, Dr. Robert C Horan, MD, Dr. Yubing Tang, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Edwin Melendez, Eileen A Liu, Emest F Bizjak, Emily A Walters, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Esteban Beltran, Felix Maldonado, Frank J Marciniak, Frederick F Razzaghi, Gayle S Lawson, George C Amedro, George Pyramides, Gianine E Tompkins, Gobiga Vanniyasingam, Guerlain Ulysse, Hala L Selby, Hala Lj Whetstone, Harry J Brewer, Helen B Ricalde, Helen Verdel, Himanshu Gupta, PhD, Iram R Hassan, PhD, James A Liubicich, James Norman, Janet A Rajan, Janet L Bowen, Jason M Sluzynski, Jay T Wong, Jean Blackston Hill, Jean M Kelahan, Jenny Sung, Jessica S Estriplet, Jill M Sooter, Jill Mielziner, Joan A Loreng, Jogy George, John A Podsadowski, Johnna L Bleem, Jonathan G Matrisciano, Jorge L Gonzalez, Jorge L Guadalupe, Jose A Lopez, Jose Acruz Gonzalez, José E Meléndez, Jose M Cayuela, Jose Ohernandez Guzman, Joseph F Mcginnis, RPh, Joseph J Vannelli, Josh Renzo N Ramilo, Joy Rkozlowski Klena, Juanita P Versace, Julianne C Mccullough, Julie Scoma, Junho Pak, Justine Tomasso, Karen A Briggs, Karen E D'orazio, Karen L Kosar, Karishma G Gopaul, Kassa Ayalew, MD, Katherine E Jacobitz, Kathleen M Jordan, Kelli F Dobilas, Kelli Regente, Kendra L Brooks, Kham Phommachanh, Kinh Q Mac, Ko U Min, Kristina L Conroy, Kristy A Zielny, Krystyna M Kitson, Kyle D Covill, Lance Mde Souza, MBA, Larry Johnson, Lata C Mathew, PhD, Laura Fontan, MS, Lauren E Skokan, Lauren L Vajo, Lawrence Harmon, Jr, Lawrence R Johnson, Leiyun Boone, PhD, Leonard H Lavi, Li Li, Liatte Kreuger, PharmD, Lily Y Koo, Linda M Hoover, Lisa B Hall, Lisa Harlan, Lisa M Bellows, Lisa Mathew, Logman A Mohamed, Loretta Nemchik, Lori M Newman, LT Colin E Tack, BSE, Luis A Dasta, Lydia I Rosas Marty, Malik S Qaiser, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcia D Fields, Marea K Harmon, Margaret E Sarles, Margaret M Annes, Margaret M Sands, Maria Estrella, Marie F Morin, Marjorie D Schultz, Mark E Parmon, Marlene G Swider, Masfin Abdi, Matthew A Spataro, Mayar M Mussa, Meena Bansal Gupta, PhD, Meisha R Sampson, Meisha Waters, Melba Trivera Clavell, Melissa A Zuppe, Melissa B Libby, Melissa T Roy, Merril E Racke, Meyer J Slobotsky, Michael C Kennedy, PhD, Michael R Klapal, Michael S Araneta, Michael Serrano, Michele Gottshall, Miguel A Martinez Perez, Minh D Phan, Miral B Patel, Monika Borkowska, Mra B Kamberem, Mra Mcculloughj, Nailing Zhang, Nancy F Scheraga, Nancy M Espinal, Neil J Bonzagni, PhD MPH, Nicholas A Violand, Nicola M Fenty Stewart, Niketa Patel, Nikki S Ramirez, Nimmy Mathews, Nina Yang, Norman K Starks, Omotunde O Osunsanmi, Paige R Mccoy, Parul M Patel, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Patsy J Domingo, Paul L Bellamy, Paula J Bretz, Peter R Lenahan, Peter S Diak, Philip F Istafanos, DMV, MS, Prabhu P Raju, Pratik S Upadhyay, DDC, Rachael A Moliver, Ramon A Hernandez, Raquel Gonzalez Rivera, Regina T Brown, Robert C Steyert, Robert D Tollefsen, Robert G Ruff, Robert Jennings, Robert Sharpnack, Rochelle L Cross, Rodney T Allnutt, Rosario D'costa, Rose Ljean Mary, Rose Xu, Russ E Davis, Russell J Glapion, S Lori Brown, PhD MPH, Sachinkumar V Patel, Saleem A Akhtar, Sam Pepe, Samir C Gala, Samuel Mindaye, Sandra A Boyd, Sandra A Hughes, Sarah Forney, Satheesh Thomas, Schultz, Sean R Marcsisin, Sena G Dissmeyer, Sharon K Thoma, PharmD, Sherri J Liu, Sherry G Bous, Shirley S Wen, Simone E Pitts, Sina Shojaee, Sinai I Davis, Srinivas R Chennamaneni, PhD, Stephanie T Durso, Stephen J Koniers, Stephen J Mottola, Stephenie M Ortiz, Suchan Kim, Susan T Hadman, Syeda N Mahazabin, Tamil Arasu, PhD, Tania E Garcia, Tania E Vizcaino, Tara G Bizjak, Tara K Carmody, Tara K Normandin, Tara R Gooen, Teresa I Navas, Thomas J Arista, Thuy T Nguyen, LCDR, Tiffani D Wilson, Tonia F Bernard, Tressa T Lewis, Tyanna N Hadley, Uduak M Inokon, Unnee Ranjan, Vivin George, Vlada Matusovsky, Walden H Lee, Wayne E Seifert, Wayne T Smith, Wei Wang, PhD, William J Leonard, Xiaohan Cai, PhD, Xiuju Lu, Yan Wang, Yonggang Wang, PhD, Yoriann M Cabrera Bartolomei, Yumi J Hiramine, Yvins Dezan, Zakaria I Ganiyu, Zhe J Tang, Zhongren Wu

Yvesna C Blaise's Documents

Publish Date Document Type Title
March, 2017 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2017-03-20
July, 2019 FDA 483 Taro Pharmaceutical Industries Ltd. - Form 483, 2019-07-11
July, 2021 FDA 483 Response Baxalta US Inc. - Form 483R, 2021-07-23
March, 2018 FDA 483 ImClone Systems LLC - Form 483, 2018-03-09
May, 2019 FDA 483 AIRGAS USA, LLC - Form 483, 2019-05-30
November, 2019 EIR Nelson Laboratories Fairfield Inc. - EIR, 2019-11-20
March, 2019 FDA 483 QUAGEN PHARMACEUTICALS LLC - Form 483, 2019-03-15
January, 2018 FDA 483 Sunrise Pharmaceutical Inc - Form 483, 2018-01-18
April, 2018 FDA 483 Amneal Pharmaceuticals LLC - Form 483, 2018-04-06
November, 2019 FDA 483 Nelson Laboratories Fairfield Inc. - Form 483, 2019-11-20
March, 2016 FDA 483 LEADING PHARMA, LLC - Form 483, 2016-03-11
April, 2019 FDA 483 KVK-TECH, INC - Form 483, 2019-04-16
July, 2016 EIR ISP Sutton Laboratories - EIR, 2016-07-27
September, 2020 FDA 483 JC World Bell Wholesale Co., Inc. - Form 483, 2020-09-09
May, 2018 FDA 483 HOVIONE FARMACIÊNCIA, S.A. - Form 483, 2018-05-18
July, 2019 FDA 483 Dead Sea Periclase - Form 483, 2019-07-18
May, 2018 EIR HOVIONE FARMACIÊNCIA, S.A. - EIR, 2018-05-18
October, 2018 FDA 483 Isomedix Operations Inc - Form 483, 2018-10-29
December, 2017 EIR Genzyme Corporation - EIR, 2017-12-07
August, 2017 FDA 483 Novel Laboratories, Inc. - Form 483, 2017-08-08
July, 2018 FDA 483 Inopak Ltd - Form 483, 2018-07-20
January, 2017 FDA 483 Glatt Air Techniques, Inc. - Form 483, 2017-01-19
July, 2021 FDA 483 Baxalta US Inc. - Form 483, 2021-07-01
August, 2017 FDA 483 Response Novel Laboratories, Inc. - Form 483R, 2017-11-30
August, 2018 EIR Avantor Performance Materials, LLC - EIR, 2018-08-03
July, 2021 EIR Baxalta US Inc. - EIR, 2021-07-01
September, 2019 FDA 483 Hikma Pharmaceuticals USA Inc. - Form 483, 2019-09-10
December, 2018 FDA 483 Unither Manufacturing LLC - Form 483, 2018-12-21
February, 2019 FDA 483 InvaTech Pharma Solutions LLC - Form 483, 2019-02-07
September, 2016 EIR Beacon Converters, Inc. - EIR, 2016-09-13
February, 2017 FDA 483 Actavis Elizabeth LLC - Form 483, 2017-02-15
March, 2017 FDA 483 Nautical Foods, LLC - Form 483, 2017-03-28
October, 2019 FDA 483 Solaris Pharma Corporation - Form 483, 2019-10-31
April, 2018 EIR Amneal Pharmaceuticals LLC - EIR, 2018-04-06
March, 2018 FDA 483 Response ImClone Systems LLC - Form 483R, 2018-03-27
February, 2020 FDA 483 Pro-Blending LLC - Form 483, 2020-02-05

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more